Brief: MGC Pharmaceuticals Says Artemic™ Receives FDA Approval In Saudi Arabia
19/12/2023 08:00
Dec 19 (Reuters) - MGC Pharmaceuticals Ltd MXC.AX :
* ARTEMIC™ RECEIVES FDA APPROVAL IN SAUDI ARABIA
* GRANTED APPROVAL FOR PROPRIETARY PRODUCT ARTEMIC BY FOOD
AND
DRUG AUTHORITY IN KINGDOM OF SAUDI ARABIA
Source text for Eikon: ID:nRSS2920Xa
Further company coverage: MXC.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Argent BioPharma
See all newsBrief: Argent Biopharma Enters Long Term Aquiol Licensing And Supply Agreement
Brief: Argent Biopharma Secures A$11M Financing Facility To Complete Strategic Acquisition
Brief: Argent Is Growing Through M&A Projected Merged Company Value Of $100M In Ac8 Asset Acquisition
Australia's Argent BioPharma set for best day in a year on AusCann deal
Brief: Argent Biopharma To Acquire Core Operating Assets And IP Portfolio Of Auscann Group